Related Experiment Video
Updated: Jul 12, 2026
10:00
Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
Published on: March 15, 2019
Diminished NO release in chronic hypoxic human endothelial cells.
Louise Ostergaard1, Edgaras Stankevicius, Malene R Andersen
1Department of Pharmacology, University of Aarhus, Aarhus, Denmark.
American Journal of Physiology. Heart and Circulatory Physiology
|August 28, 2007
Summary
Chronic hypoxia significantly reduces nitric oxide (NO) release by decreasing endothelial NO synthase (eNOS) expression and activity in human umbilical vein endothelial cells (HUVECs). This impaired NO production may worsen endothelial dysfunction in cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Cellular Physiology
- Hypoxia Research
Background:
- Nitric oxide (NO) plays a crucial role in maintaining endothelial function.
- Endothelial NO synthase (eNOS) is the primary source of NO in the vasculature.
- Chronic hypoxia is a condition linked to various cardiovascular diseases.
Purpose of the Study:
- To investigate the impact of chronic hypoxia on NO release from endothelial cells.
- To determine the effect of chronic hypoxia on endothelial NO synthase (eNOS) activation and expression.
- To elucidate the molecular mechanisms underlying hypoxia-induced changes in NO production.
Main Methods:
- Primary human umbilical vein endothelial cells (HUVECs) were exposed to varying oxygen levels (normoxia, acute hypoxia, chronic hypoxia).
- Nitric oxide (NO) release was measured using a NO microsensor.
- eNOS activity, phosphorylation status (Ser1177, Thr495), intracellular calcium levels, and protein expression (eNOS, Akt, beta-actin) were assessed.
Main Results:
- Chronic hypoxia (24h at 5% or 1% O2) significantly reduced histamine-stimulated NO release compared to acute hypoxia.
- Hypoxia led to decreased eNOS expression, activity, and altered phosphorylation patterns.
- Reduced intracellular calcium, decreased Akt kinase activity, and lower beta-actin levels were observed under chronic hypoxia.
Conclusions:
- Chronic hypoxia impairs NO bioavailability by reducing eNOS expression and activity in HUVECs.
- Altered eNOS phosphorylation and reduced Akt activation are key mechanisms contributing to decreased NO production.
- The findings suggest that chronic hypoxia-induced reduction in NO may exacerbate endothelial dysfunction in cardiovascular pathologies.
Related Concept Videos
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...